Zheng T, Tr H, Ma Z, Ba W, Flannery, Boyle P. Continuing increase in the incidence of germ-cell testis cancer in young adults: experience from Connecticut. Int j Cancer. 1996;723–9.
2.
Ward E. Cancer statistics. Ca Cancer j Clin. 2009;225–49.
3.
Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worlwide: a review. Urol. 2003;5–11.
4.
Drazer G, M, Se E. Global trends in testicular cancer incidence and mortality. Eur Urol. 2011;374–9.
5.
Mc Glynn K. Trens in the incidence of testicular germ cell tumours in the United states. Cancer. 2001;63–70.
6.
Chia V, Quarishi, Purdue M, Cook M, Mc G, Ka. International treens in the incidence of testicular cancer. Cancer Epidemiologic Biomarkers Prev. 1973;1151–9.
7.
Ca C, Chilvers C, Davey G, Pikl M. Oliver rT; Forman dT. risk facors for testicular tumors by histological tumour type. United kingdom Testicular Cancer study Group. Br j Cancer. 1999;1859–63.
8.
Hj H. Van der Graft WT, shuiter Wj, Chraffordt Koops H, sleifer dT. The changing distribution of stage in nonseminomatous germ cell tmors, from 1977 to 1996. BjU Int. 1998;68–74.
9.
Heindal K, Sd F. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-87. Br j Cancer. 1990;277–8.
10.
Powles T, Bhardwa, Mandalia, Oliver T. The changing presentation of germ cell testicular tumours of the testis between. BjU Int. 1983;1197–200.
11.
Enewold L, Erickson Rl Z, Zhu K, Mc G, Ka. Trends in testicular germ cell tumors among U.s. military servicemen, 1990-2003. Mil Med. 2011;1184–7.
12.
Gj B, Nj V, Goldman. Impact of delay in diagnosis on clinical stage testicular cancer. Lancet. 1981;970–3.
13.
Chilvers C, Saunders M, Biss Jm, Nicholls, Horwich. Influnce of delay in diagnosis on progression in testicular teratoma. Br j Cancer. 1989;126–8.
14.
Moul Jw, Paulson W, Pj. delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. j Urol. 1990;520–3.
15.
Weir H, Ld M, Moravan V. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996. Can Med assoc j. 1999;201–5.
16.
Oliver Rt, Leahey M, Ong J. Combined seminoma/non-seminoma should be considered as intermediate grade germ cell cancer (GCC). Eur j Cancer. 1995;1392–4.
17.
Berney Dm L, Rt O. Tzhe frequency of intratubular embryonal carcinoma: implications for the pathogenesis of germ cell tumors. Histopatology. 2004;155–61.
18.
Bray F, Ekborn L. do testicular seminoma and nonseminoma have the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight european countries. Cancer Epidemiologic Biomarkers rev. 2006;652–8.
19.
Pearce N, Howard Jk F, Lilley B. Time trends and occupational differences in cancer of the testis in New Zeland. Cancer. 1987;1677–82.
20.
Pukkala E, Weiderpass E. socio-economic differences in incidence rates of cancer of the male genital organs in Finland, 1975-95. Int j Cancer. 2002;643–8.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
